Sign in
Taking peopleNo phase

Trauma Molecular Processes

Key facts

Who runs it
Mario Negri Institute for Pharmacological Research
Where
Italy2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
500 people, planned
Started
18 Oct 2024
Expected to end
Oct 2044
Type of study
Observational
Record updated
6 July 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Adults aged ≥18 years
  • Diagnosis of traumatic brain injury (TBI)
  • Admission to the intensive care unit
  • Clinical indication for neurosurgical evacuation of a cerebral contusion
  • Written informed consent to participate to the study

Who cannot take part

  • Coagulation disorders or other contraindications to the planned neurosurgical procedure

This trial is currently available in Italy.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The TRAUMAP study will function as a brain tissue repository for biopsy specimens from patients with traumatic brain injury undergoing brain surgery for contusion removal.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Study of Pathological and Regenerative Molecular and Cellular Processes Triggered After Traumatic Brain Injury: Analysis of Biopsy Specimens
Record updated
6 July 2026